Menu
.

Posts tagged "Biotechnology"

Portola Pharmaceuticals inks lucrative deal with Merck

For those of you tracking the growing numbers of huge deals between the Bay Area's formidable array of biotech companies and those gargantuan drug firms known as Big Pharma, here's yet another: Portola Pharmaceuticals of South San Francisco and New Jersey-based Read More →

Top Genentech exec named UCSF chancellor

When Roche first began maneuvering to take complete control of Genentech, the air was thick with speculation that the Swiss drug giant's plans would force out some of the South San Francisco company's top talent. Sure enough, upon completing the deal Read More →

CV Therapeutics-Gilead Sciences deal sparks lawsuit

The $1.4 billion deal that Foster-City based Gilead Science's announced March 12 to buy CV Therapeutics of Palo Alto has triggered a class-action shareholder lawsuit. The legal action, which CV Therapeutics disclosed today in a filing with the U.S. Securities and Read More →

Genitope sees $1 buy 8.1 million of its shares Wednesday

Genitope, the beleaguered Fremont biopharmaceutical that halted development of its experimental MyVax treatment for non-Hodgkin’s lymphoma last March after the Food and Drug Administration said at least one Read More →

Private placement of Aryx stock sends shares soaring

Aryx Therapeutics, the Fremont biopharamaceutical whose shares were slammed last July when Procter & Gamble pulled out of a partnership in developing Aryx's drug to treat chronic constipation Read More →

XenoPort shares dive after new drug application withdrawal

XenoPort of Santa Clara and its partner said Monday they withdrew their new drug application for Solzira, its time-released treatment of moderate-to-severe restless drug syndrome after Read More →

Back to top

Archives

Categories